Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8291-8300 Newer>

Fast Company April 2012 Lindsey Kratochwill	Shelley Schoepflin Sanders' System Saves Lives Before They Need Saving This year, the U.S. government started a program for health-care innovators. One innovator, Shelley Schoepflin Sanders implemented a modified early warning system in her home hospital to monitor multiple aspects of patients' health.
Fast Company April 2012 Christina Chaey	Srikant Iyer Streamlines Patient Care In Hectic Emergency Rooms This health-care innovator uses a different kind of triage system to identify who is very ill and who is mildly ill, keeping emergency room care moving.
Fast Company April 2012 Christina Chaey	Stevi Riel Provides Partnerships With Hospitals To Find Affordable Help For Patients This year, the U.S. government started a program for health-care innovators. One innovator, Stevi Riel takes what physicians are too busy to do, and partners with hospitals to find affordable prescription solutions for underinsured patients.
Fast Company April 2012 Lindsey Kratochwill	How Jay Want Prescribes A Change In The Business Of Paying For Health Care This year, the U.S. government started a program for health-care innovators. One innovator, Jay Want sees a more efficient and cost-effective future for healthcare payments.
Pharmaceutical Executive March 12, 2012 William Looney	Novartis: LEADing in Emerging Markets With growth as its guiding light, Novartis has big plans for the emerging markets. CEO Joe Jimenez tells us what it will take the company to best the competition.
Pharmaceutical Executive March 1, 2012 Ringler & Comer	The (Life) Science of Digital Connections Making real connections that resonate with audiences in a digital world is a fine art, especially in the heavily regulated world of Big Pharma
Pharmaceutical Executive March 1, 2012 Paolo De Marino	Registering Value: Always in the Eye of the Beholder The organizational disconnect between marketing and market access is curable if both groups focus on what counts: who's making the final purchase.
Pharmaceutical Executive March 1, 2012 Sillup & Porth	Pharma & The Press Our eighth annual press audit finds the industry out of the crosshairs for now.
Pharmaceutical Executive March 1, 2012 Jill Wechsler	When Talk is Not So Cheap FDA and industry are pushing user fees, while they struggle with curbs on communications.
Pharmaceutical Executive March 1, 2012 Ben Comer	Betting on Bigger Data Can endless information explain what makes us human? The benefit to health outcomes that such self-surveillance could supply is undeniable.
<Older 8291-8300 Newer> Return to current articles.